Both in Pharmaceuticals
Stoke Therapeutics vs Precigen
Over the past year STOK returned +8.3% and PGEN returned +30.3%; their daily moves had a correlation of 0.22.
STOK +8.3% PGEN +30.3%Growth of $1, one year, split-adjusted
| Metric | STOK | PGEN |
|---|---|---|
| Price | $27.45 | $5.06 |
| Market cap | $1.77B | $1.81B |
| Today | +1.70% | −3.71% |
| 1 month | +12.6% | −33.0% |
| 6 months | −17.5% | +14.9% |
| Year to date | −13.5% | +20.9% |
| 1 year | +5.2% | +21.5% |
| Revenue growth (YoY) | +5.9% | +6322.7% |
| Gross margin | 100.0% | 94.9% |
| Net margin | −654.3% | 36.5% |
| P/E (TTM) | — | — |
| Price / sales | 62.8× | 21.1× |
| Net cash | $319.2M | -$55.7M |
| Dividend yield | — | — |
| Volatility (60d) | 47.9% | 86.8% |
| Short % of float | 18.9% | 26.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).